Jubilant Pharmova Ltd
BSE: 530019
Revenue & Profit Trend
in croresMargin Trend
percentage| Period | Q2 FY27 | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 68.50+2.1% | 67.10-4.6% | 70.30+4.5% | 67.30+1.4% | 66.40+11.6% | 59.50-72.6% | 217.30+10.9% | 196.00 |
| Other Income | 0.90+800.0% | 0.10-80.0% | 0.50+25.0% | 0.40-50.0% | 0.80+14.3% | 0.70-96.1% | 17.90-2.7% | 18.40 |
| Total Income | 69.40+3.3% | 67.20-5.1% | 70.80+4.6% | 67.70+0.7% | 67.20+11.6% | 60.20-74.4% | 235.20+9.7% | 214.40 |
| EXPENSES | ||||||||
| Expenditure | 59.10+3.0% | 57.40-1.0% | 58.00+0.7% | 57.60-1.9% | 58.70+9.3% | 53.70-74.6% | 211.70+2.9% | 205.70 |
| Tax | 2.70+8.0% | 2.50+104.7% | -53.10-1617.1% | 3.50-93.8% | 56.50+2254.2% | 2.40-75.8% | 9.90+191.2% | 3.40 |
| PROFIT | ||||||||
| PBT | 10.30+5.1% | 9.80+139.0% | 4.10-59.4% | 10.10+18.8% | 8.50+30.8% | 6.50-72.3% | 23.50+170.1% | 8.70 |
| Net Profit | 7.60+4.1% | 7.30-87.2% | 57.20+766.7% | 6.60+203.1% | -6.40-210.3% | 5.80-57.4% | 13.60+156.6% | 5.30 |
| KEY METRICS | ||||||||
| OPM % | 17.08%-0.80pp | 17.88%+9.63pp | 8.25%-9.88pp | 18.13%+0.36pp | 17.77%+0.46pp | 17.31%+5.34pp | 11.97%+27.48pp | -15.51% |
| NPM % | 10.95%+0.09pp | 10.86%-69.93pp | 80.79%+71.04pp | 9.75%+19.27pp | -9.52%-19.15pp | 9.63%+3.85pp | 5.78%+3.31pp | 2.47% |
| EPS | 0.48+4.3% | 0.46-87.2% | 3.59+754.8% | 0.42-86.1% | 3.02+1061.5% | 0.26-69.8% | 0.86+160.6% | 0.33 |
Corporate Events
Board Meeting
The meeting of the Board of Directors is scheduled to consid…
BSE Filing ↗Board Meeting
The Finance Committee of the Company approved the allotment …
BSE Filing ↗Board Meeting
The Board of Directors meeting is scheduled to consider and …
BSE Filing ↗Board Meeting
The 48th AGM will be held to receive, consider and adopt fin…
BSE Filing ↗Board Meeting
The 48th AGM will be held on August 26, 2026. The agenda in…
BSE Filing ↗Board Meeting
The meeting of the Board of Directors of the Company is sche…
BSE Filing ↗Board Meeting
The Board of Directors recommended payment of final dividend…
BSE Filing ↗Board Meeting
Inter-alia consider and approve Unaudited Standalone and Con…
BSE Filing ↗Board Meeting
Consider and approve Audited Standalone and Consolidated Fin…
BSE Filing ↗Board Meeting
Consideration and approval of Board Meeting Intimation for u…
BSE Filing ↗Board Meeting
Consider and approve Unaudited Standalone and Consolidated F…
BSE Filing ↗